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Abstract. 
 
Carcinoembryonic antigen (CEA) is a tumor 
marker that is overexpressed in many human cancers 
and functions in vitro as a homotypic intercellular ad-
hesion molecule. We have investigated the possibility 
of synergy between CEA, v-Myc, and Bcl-2 in the 
transformation of cells with differentiation capacity. 
We find that v-Myc increases the cell division rate and 
maximum density of rat L6 myoblasts but also mark-
edly stimulates both apoptosis and surprisingly, differ-
entiation, thus preventing transformation. The super-
position of Bcl-2 blocks the apoptotic stimulation of 
v-Myc and independently promotes further cell division 
at confluence, but still allows differentiation. The fur-
ther expression of CEA has a dominant effect in block-
ing differentiation, regardless of the presence of the 
other activated oncogenes, generating cells that enter a 
 
reversible quiescent G
 
0
 
-like state in medium promoting 
differentiation. Transfectants expressing CEA with or 
 
without 
 
v-myc
 
 and 
 
bcl-2
 
 allow the emergence of cells 
with the property of heritable, efficient, anchorage-
independent growth in soft agar and the ability to 
markedly reduce the latency for tumor formation in 
nude mice. We propose that by prolonging cell survival 
in the presence of differentiation signals, CEA repre-
sents a novel class of dominant differentiation-blocking 
oncogene.
 
M
 
alignant
 
 transformation is believed to require
four critical events: acquisition of increased pro-
liferative activity, abrogation of apoptosis, im-
mortalization, and deletion of access to differentiation
programs. Differentiation has generally been assumed to
be attenuated by an increase in proliferative behavior, if
only because these cellular programs are considered mutu-
ally inhibiting. A major focus of oncobiology, therefore,
has been to identify and characterize genes that influence
cellular proliferation and recently, genes that govern cell
death. Prototypic members of these two classes of onco-
genes are, respectively, 
 
c-myc
 
 (for reviews see Evan and
Littlewood, 1993; Evan et al., 1994) and 
 
bcl-2
 
 (for reviews
see Korsmeyer, 1992; 1995).
 
c-myc
 
 is an early response gene implicated in emergence
from quiescence and normal progression through the cell
cycle, in the establishment and propagation of neoplasia
and, paradoxically, in initiating apoptosis (for review see
Evan and Littlewood, 1993; Packham and Cleveland,
1995). Cellular transformation induced by 
 
c-myc
 
 deregula-
tion is, however, often incomplete and depends on the ac-
tivation of another oncogene, such as 
 
ras
 
 (Land et al.,
1983; Adams et al., 1985). In contrast, forced 
 
bcl-2
 
 expres-
sion promotes cell survival both in vitro (Bissonnette et al.,
1992; Fanidi et al., 1992) and in vivo (McDonnell et al.,
1989; McDonnell and Korsmeyer, 1991) by preventing apop-
tosis. Cultured fibroblasts coexpressing 
 
myc
 
 and 
 
bcl-2
 
 con-
tinue to proliferate at low mitogen concentrations and
experience reduced cell death but are not morphologically
transformed (Fanidi et al., 1992). Mice expressing both
 
E
 
m
 
-
 
myc
 
 and 
 
E
 
m
 
Ð
 
bcl
 
-
 
2
 
 transgenes (Strasser et al., 1990) ac-
cumulate cycling pre-B and differentiated B cells, display
an increased frequency of monoclonal tumors, and die ear-
lier than 
 
E
 
m
 
-
 
myc
 
 mice (Adams et al., 1985), observations
that are attributed to a tumorigenic cooperativity between
Myc and Bcl-2. The latent period and monoclonal nature
of the tumors suggest, however, that additional mutations
are required. Thus, Myc and Bcl-2 together result in the
expansion of a population of benign cells that retain, at
least in part, the capacity for differentiation.
Our laboratory has used a well characterized in vitro dif-
ferentiation system, the immortal rat L6 skeletal myoblast
cell line (Yaffe, 1968), to investigate oncogene action in
the context of aberrant expression of human carcinoem-
bryonic antigen (CEA).
 
1
 
 First discovered to be overex-
pressed in human colon tumors (Gold and Freedman,
1965), CEA has since been widely used as a marker in the
clinical management of many cancers, including carcino-
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Abbreviations used in this paper
 
: CEA, carcinoembryonic antigen; DM,
differentiation medium; GM, growth medium.
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mas of the colon, breast, and lung (Averbach and Sugar-
baker, 1995). CEA is a glycophosphatidylinositol-linked
(Hefta et al., 1988; Takami et al., 1988) cell surface glyco-
protein of the immunoglobulin gene superfamily that has
been shown to mediate homotypic intercellular adhesion
(Benchimol et al., 1989; Oikawa et al., 1989).
We have proposed a model in which overproduction of
CEA plays an active role in carcinogenesis by disrupting
the normal tissue architecture of colonic epithelium, lead-
ing to inhibition of differentiation and tissue dysplasia
(Benchimol et al., 1989). We contend that overproduction
and redistribution of CEA from apical to the lateral and
basal surfaces of colonic crypt epithelial cells perturbs nor-
mal intercellular interactions leading to the adoption of a
multilayered (ÒstratifiedÓ) epithelial configuration, per-
haps mimicking the multilayered configuration seen in
embryonic colonic epithelium. The predicted effect of this
distortion in tissue architecture is the inhibition of normal
colonocyte terminal differentiation, thus potentiating in-
creased cell division. In support of this model we have re-
cently shown that the cell surface levels of CEA deter-
mined by cytofluorometric analysis of highly purified
epithelial colonocytes from freshly excised colon carcino-
mas and adjacent normal tissue are elevated in the tumor
cells and at levels that are inversely correlated with the de-
gree of differentiation of the tumors (Ilantzis et al., 1997).
To test the proposed differentiation-inhibiting effect of
CEA directly in a well defined differentiation system, rat
L6 myoblasts were used. In low serum, L6 cells withdraw
irreversibly from the cell cycle, align, and form multinucle-
ated myotubes while concomitantly upregulating muscle-
specific gene products (Nadal-Ginard, 1978). Myogenesis
of L6 cells requires a complex series of cellÐcell recogni-
tion and membrane fusion events that are mediated by a
number of adhesion systems (Knudsen, 1990) and the up-
regulation of functional Myf5 and myogenin, members of
the MyoD family of skeletal muscle transcriptional regula-
tors (for review see Olson and Klein, 1994). Ectopic expres-
sion of cell surface CEA blocks biochemical and morpho-
logical myogenic differentiation in L6 myoblasts (Eidelman
et al., 1993); since the CEA-imposed differentiation block
can be released by peptides representing the two adhesion
domains of CEA, the effect depends on CEAÐCEA inter-
actions (Eidelman et al., 1993; Zhou et al., 1993). We hy-
pothesized that L6 cells stably expressing CEA, which re-
tain their viability and proliferative potential while remaining
in a quiescent nondifferentiated state for weeks in differ-
entiation medium (Eidelman et al., 1993; Screaton, R.A.,
and C.P. Stanners, unpublished observations), should
show increased susceptibilty to further malignant progres-
sion induced by oncogenic activation. To directly test this
idea we have examined cellular phenotypes in single and
multiple transfectants of the rat L6 and mouse C2 (Yaffe
and Saxel, 1977) myoblast cell lines to examine possible
synergism between Myc, Bcl-2, and CEA in transforma-
tion.
Extensive evidence has led to the prevailing view that
activation of the cellular proliferative machinery results in
the obligatory disruption of the myogenic differentiation
program, which is normally accessed after arrest in the G
 
1
 
phase of the cell cycle. Specifically, myogenesis can be pre-
vented by maintaining cells in high concentrations of solu-
 
ble growth factors such as PDGF and IGF-I (Screaton,
R.A., and C.P. Stanners, unpublished) and by the forced
expression of cellular or viral oncogenes (for review see
Alema and Tato, 1994), including 
 
c-myc
 
 (Denis et al.,
1987; La Rocca et al., 1994) and 
 
v-myc
 
 (La Rocca et al.,
1989). The mechanism of disruption has been suggested to
involve either the stimulation of proliferative behavior,
which precludes cell cycle withdrawal, or the direct inacti-
vation of Myf5 (Braun et al., 1992). We present data show-
ing that 
 
v-myc
 
 expression in L6 cells increases the division
rate and saturation density, promotes cell death by apop-
tosis in limiting serum, and contrary to previous reports,
accelerates myogenic differentiation. Superimposed ex-
pression of 
 
bcl-2
 
 relieves cell loss due to apoptosis and in-
dependently promotes further cell division at confluence
but does not prevent differentiation. In low serum, CEA
induces a reversible quiescent G
 
0
 
-like state that is incom-
patible with progression to terminal differentiation. We
demonstrate that cells expressing CEA in addition to 
 
v-myc
 
and 
 
bcl-2
 
 proliferate faster, reach higher saturation densi-
ties, neither undergoes apoptosis nor differentiates in low
serum, and furthermore, are capable of giving rise to large
anchorage-independent colonies that form tumors in nude
mice. CEA is the critical factor in allowing the emergence
of these colonies and in reducing the latent period of tu-
mor formation. These results suggest that CEA may con-
tribute to malignancy in myoblasts by interfering exclu-
sively with access to the differentiation program, inducing
reversible quiescence in the presence of differentiation
stimuli and increased susceptibility to proliferative onco-
gene activation.
 
Materials and Methods
 
Cell Culture
 
Rat L6 (Yaffe, 1968) and mouse C2 (Yaffe and Saxel, 1977) myoblasts
were grown as monolayer cultures in DME containing 10 (L6) or 20%
(C2) FBS growth medium (GM; GIBCO BRL, Gaithersburg, MD) sup-
plemented with 100 U/ml penicillin and 100 
 
m
 
g/ml streptomycin (GIBCO
BRL) and were incubated at 37
 
8
 
C in a humidified atmosphere with 5%
CO
 
2
 
. 
 
v-myc
 
 and CEA coexpressing transfectant cells were maintained in
medium containing 20% FBS to minimize cell death by apoptosis in me-
dium depleted of growth factors. All cells were passaged while subconflu-
ent to avoid selection of nonfusing variants.
 
Infections
 
L6 cells were incubated with replication-defective recombinant retrovirus
containing either 
 
pBabe(avian v-myc)hygro
 
 (Facchini et al., 1994),
 
pBabe(human bcl-2)puro
 
 (Zhu et al., 1996), or the vector alone controls
(Morgenstern and Land, 1990) in 2.5 ml 
 
a
 
-MEM plus 10% FBS supple-
mented with 8 
 
m
 
g/ml polybrene for 2 h at 37
 
8
 
C. Cells were then washed
and incubated with GM overnight. The cultures were subcultured 1:5 to 1:20
and selection started 24 h later with GM containing hygromycin B (
 
v-myc
 
)
or puromycin (
 
bcl-2
 
) at 100 
 
m
 
g/ml and 2 
 
m
 
g/ml, respectively. After 7 d of
selection, selective drugs (hygromycin or puromycin) were removed, and
total populations of resistant clones were pooled and cultured thereafter
without selection. v-Myc and Bcl-2 expression was verified by immuno-
blotting. Total populations were used to avoid the possibility of clonal
variation in cellular properties unrelated to the phenotypic effects of the
gene being tested. Proof of the polyclonality of these populations was pro-
vided by the presence of multiple integration sites in genomic DNA from
the appropriate cell populations as revealed by Southern analysis using
cDNA-specific probes for 
 
v-myc
 
 and 
 
bcl-2
 
 (not shown). Cultures used for
experiments were obtained from frozen stocks incubated for relatively
few doubling times. The observed effects on cellular phenotype were re- 
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produced with distinct total populations generated by repeating the infec-
tions for 
 
v-myc
 
 and 
 
bcl-2.
 
 No loss of v-Myc and Bcl-2 was noted during the
course of the experiments (not shown). A triple selection with G418 (for
CEA, see below), hygromycin, and puromycin done in separate steps al-
lowed for the isolation of a population of cells expressing CEA, 
 
v-myc
 
,
and 
 
bcl-2.
 
Transfections
 
L6 or C2 myoblasts were seeded at 2 
 
3
 
 10
 
5
 
 cells/100-mm dish and cotrans-
fected 24 h later by calcium phosphate coprecipitation with 5 
 
m
 
g of
p91023B expression vector (courtesy of Kaufman, R., Genetics Institute,
Boston, MA) or PKJ expression vector containing full-length CEA cDNA
(clone 17; Beauchemin et al., 1987) and 0.5 
 
m
 
g pSV2neo plasmid per dish.
Neomycin (G418)-resistant total transfectant populations were selected
with 400 
 
m
 
g/ml G418 for 10Ð14 d. G418-resistant clones were pooled and
sorted for high surface CEA levels by FACS using polyclonal rabbit antiÐ
human CEA antibody. To enrich for stable CEA-producing cells, sorted
populations were cultured without G418 selection for 
 
z
 
20 doubling times,
resorted for residual high CEA producers, and subsequently maintained
in GM containing G418. Proof of polyclonality was provided by Southern
analysis of genomic DNA using a CEA cDNA probe: pooled, sorted, and
stabilized populations showed numerous integration sites and distinct pat-
terns when using both CEA and 
 
neo
 
 specific probes in three out of the five
independent clones isolated from the final sorted L6C population (not
shown). Transfectant clone L6(CEA-1) was generated previously and des-
ignated L6-17 (Eidelman et al., 1993). G418 was removed from growth
media 24 h before the application of the various functional assays. No loss
of surface expression of CEA was detected over the culture period re-
quired for the assays (not shown).
 
Differentiation Assays
 
To induce differentiation, L6 and C2 cells were seeded on day 0 at 7 
 
3
 
 10
 
3
 
and 3.5 
 
3
 
 10
 
3
 
 cells/cm
 
2
 
, respectively, in 60-mm plastic tissue culture petri
dishes in 4 ml DME plus 10% FBS. On day 3, when cells were nearly con-
fluent, the medium was changed to DME containing 2% horse serum (dif-
ferentiation medium [DM]). Cells were assessed for differentiation/fusion
on day 7 unless otherwise noted. Fusion index was determined as de-
scribed previously (Eidelman et al., 1993). To investigate proliferation and
differentiation capabilities of cells in medium containing low serum, cells
were seeded on day 0 directly in DM at concentrations listed above and
after 4 d incubation, fixed with 2.5% glutaraldehyde in PBS, and stained
with hematoxylin. As a further assay of differentiation, cells were seeded
in GM at 200 cells/60-mm petri dish, incubated for 10 d without a change
of medium, as described for the viability assay, and then stained as above.
The percentage of colonies with fused cells in their nonproliferating cen-
ters was then determined. For anti-myosin immunofluorescent staining,
cultures were induced to differentiate in multiwell chamber slides (Nun-
clon
 
¨
 
; Nunc, Inc., Naperville, IL) and prepared as described (De Giovanni
et al., 1993).
 
Cell Lysis and Immunoblotting
 
Cells at a concentration of 10
 
7
 
/ml were boiled in SDS lysis buffer (100 mM
Tris, pH 8.0, 10% glycerol, 2% SDS) for 5 min and clarified by centrifuga-
tion. Protein determinations were made using BCA reagent (Pierce,
Rockford, IL). 50Ð100 
 
m
 
g total protein was resolved by SDS-PAGE and
transferred electrophoretically to a 0.45 
 
m
 
m PVDF membrane (Millipore
Corp., Bedford, MA). Membranes were incubated with polyclonal pan-
Myc antibody (generously provided by Evan, G.I., Imperial Cancer Re-
search Fund, London, UK) at a dilution of 1:1,000 or polyclonal antiÐBcl-2
antibody (kind gift of Andrews, D., McMaster University, ON, Canada) at
a dilution of 1:5,000 for 1 h at 25
 
8
 
C in TBST/M (25 mM Tris, pH 8.0, 62.5
mM NaCl, 0.4% Tween, 10% milk). After extensive washing, membranes
were developed with HRP-conjugated antiÐrabbit antibody and visualized
by ECL reagent (Amersham Life Science, Pittsburgh, PA), which was
used according to manufacturerÕs instructions.
 
Growth Curves
 
2 
 
3
 
 10
 
4
 
 L6 cells were seeded in 60-mm dishes in GM. Triplicate cultures
were rendered single cell suspensions by trypsinization every 24 h and
their cell numbers individually determined using a particle counter
(Coulter Electronics Inc., Hialeah, FL). Plates were not refed fresh me-
 
dium during the course of the experiment. Cell size distributions were ob-
tained using a channelyzer (Coulter Electronics Inc.), and their mean val-
ues were determined. All distributions were essentially symmetrical such
that mean and mode values were equivalent.
 
Cell Viability Assay
 
200 cells (or nuclei equivalent, where cell fusion was appreciable) were
seeded in GM in replicate 60-mm dishes and incubated at 37
 
8
 
C for 9Ð10 d.
The resultant colonies were rinsed with PBS, fixed with 3.7% formalde-
hyde in PBS, and stained with 0.1% methylene blue. The number of colo-
nies of 
 
.
 
25 cells was determined by eye and expressed as a percentage of
the number of cells seeded to give the plating efficiency.
 
Colony Formation in Soft Agar
 
10
 
3
 
 cells were seeded in 60-mm dishes in 0.3% agar in 5 ml GM on a bot-
tom layer of 0.5% agar in 3 ml GM and incubated at 37
 
8
 
C. Plates were not
refed during the course of the experiment. Uniform, dense colonies of
 
.
 
100 or 
 
.
 
500 cells were counted by microscopic observation 3Ð4 wk after
seeding, as indicated.
 
Chromatin Staining and Apoptotic
Frequency Determination
 
Cells were seeded for differentiation in 60-mm dishes in GM. The culture
medium was changed to DM on day 2 and incubated for an additional 24 h, at
which time the cultures were trypsinized and the resultant cell suspension
pooled with nonadherent cells in the medium and centrifuged. Cell pellets
were resuspended in 1 ml DME, and an equal volume of ice-cold fixative
(3:1 ratio of 95% EtOH to glacial acetic acid) was added dropwise with in-
termittent vortexing. Cells were collected by centrifugation, resuspended
in 1 ml of fixative, and incubated on ice for 10 min. Fixed cells were centri-
fuged, resuspended in 200 
 
m
 
l fixative, mounted on cold slides, and quick
dried over a boiling water bath. Slides were immersed in a saturated solu-
tion of orcein in 50% glacial acetic acid for 30Ð60 min at 25
 
8
 
C. Damaged
cells with condensed chromatin, confirmed by electron microscopy to be
apoptotic, were easily distinguished; their numbers relative to undamaged
cells were determined in six separate fields. A minimum of 300 cells was
counted per field.
 
Transmission Electron Microscopy
 
Cells were incubated in DM for 24 h, as described above for chromatin
staining, before fixation in 2.5% glutaraldehyde and processed for elec-
tron microscopy using standard procedures. Cells were viewed under an
electron microscope (Philips Electronic Instruments, Inc., Mahwah, NJ).
 
FACS
 
 
 
Analysis
 
Cultures were trypsinized and resuspended in ice cold PBS plus 2% FBS
(PBSF). 2.5 
 
3
 
 10
 
5
 
 cells were incubated with polyclonal rabbit or goat anti-
CEA antibodies diluted 1:100 (rabbit) or 1:600 (goat) in a total volume of
0.5 ml PBSF for 30 min on ice. Cells were centrifuged, rinsed with 2 ml
PBSF, and resuspended in 0.5 ml PBSF containing FITC-conjugated rab-
bit antiÐgoat or goat antiÐrabbit antibody diluted 1:100. After 30 min incu-
bation on ice, cells were rinsed and resuspended in 0.75 ml PBSF for cyto-
fluorometric analysis (FACScan
 
¨
 
; Becton Dickinson, Bedford, MA).
 
Tumorigenicity Assay
 
To assay for tumorigenicity, 8Ð9 wk old nude mice (Swiss nu/nu; Taconic
Farms Inc., Germantown, NY) were injected intramuscularly in both hind
legs with cells resuspended in 100 
 
m
 
l serum-free PBS. The average latent
periods for tumor formation by 10
 
5
 
 and 3 
 
3
 
 10
 
5
 
 injected cells (or 5 
 
3
 
 10
 
5
 
cells in the case of M alone) were determined as the time of appearance of
a visible mass (
 
.
 
0.5 cm in diameter) at the site of injection or, for cases in
which tumors developed inside the leg, the time of visible swelling of the
leg and/or an alteration in gait. Differences in tumor latency were evalu-
ated using the StudentÕs 
 
t
 
 test.
 
Tumor Resection and Dissociation
 
Freshly excised tumor tissue was rinsed well with cold PBS, finely minced,
and incubated in a sterile-filtered solution containing 50 U/ml purified col- 
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lagenase (CLSPA) and 0.13% CLS-2 collagenase (Worthington Biochem.
Corp., Freehold, NJ) in PBS supplemented with 10 
 
m
 
g/ml DNAseI for 30Ð
45 min at 37
 
8
 
C. After washing with GM to stop the dissociation, cells were
filtered through a 70-
 
m
 
m filter and collected by centrifugation. Cells were
seeded in GM containing 50 
 
m
 
g/ml gentamycin. 24Ð36 h later, cultures
were divided by trypsinization and introduced into selective media con-
taining either G418 (CEA
 
1
 
 lines) or puromycin (Bcl-2
 
1
 
 lines). After 3 d
growth under selection, these tumor lines (denoted t) were expanded and
then reintroduced into soft agar and nude mice.
 
Results
 
The block in myogenic differentiation of L6 cells stably ex-
pressing CEA in DM (Eidelman et al., 1993) led to the hy-
pothesis that ectopic CEA expression could contribute to
transformation of myoblasts in conjunction with a prolifer-
ative stimulus provided by an activated oncogene. Avian
v-Myc and its cellular homolog, c-Myc, are cell cycle acti-
vators that promote G
 
0
 
ÐG
 
1
 
 and G
 
1
 
ÐS transitions (Evan
and Littlewood, 1993, and references therein). Pooled
populations of L6 cells stably expressing v-Myc in a retro-
viral vector conferring hygromycin B resistance (M) or of
L6 cells expressing the drug resistance gene of the vector
alone (P, parental) were therefore generated; expression
of the p110 gagÐv-Myc viral protein was verified by immu-
noblot (Fig. 1 
 
A
 
).
 
Ectopic Myc Expression Accelerates
Proliferation and Induces Both Apoptosis and 
Differentiation in Myoblasts
 
To investigate the effects of v-Myc alone on the growth
behavior of L6 myoblasts, M and P cells were seeded in
replicate culture dishes in GM and their cell numbers de-
termined daily without change of medium; the results for a
single experiment typical of three separate experiments,
which included transfectants expressing Bcl-2 and CEA
(see below), are shown in Fig. 2. The population doubling
times are revealed by the slopes of the curves and are re-
ported along with initial (day 5) and final (day 15) satura-
tion densities in the inset of Fig. 2. v-Myc expression in-
creased both the proliferation rate and the maximum
culture density (Fig. 2, 
 
inset
 
, compare 
 
P
 
 and 
 
M
 
). These rel-
atively small differences were highly significant and repro-
ducible in repeated experiments. Cells expressing v-Myc
were reduced in size during the exponential growth phase
(Fig. 3), which is consistent with the observed increase in
proliferative rate (Murray and Hunt, 1993).
On day 5, cultures expressing ectopic Myc alone began
to acidify the medium and display cell death. Coincident
with this, marked cell elongation and alignment and the
formation of multinucleated myotubes were also apparent.
These changes are reflected in the complete loss of viabil-
ity as measured by colony-forming ability after 15 d in cul-
ture (Fig. 2, 
 
inset
 
) and in the increase in average size of M
cells nearing saturation (Fig. 3). To investigate the effect
of v-Myc on differentiation, P and M cells were tested in
two different assays in which serum growth factors be-
come limiting. First, we quantified the effect of growth fac-
tor depletion in the nonproliferating centers of cell colo-
nies (Fig. 4). 75% of M colonies, obtained by plating viable
M cells from the exponential growth phase, showed myo-
tubes in their centers after 10 d of incubation in GM,
whereas P colonies showed no myotubes under these con-
ditions (Fig. 4), thus indicating a dramatic increase in the
propensity for differentiation. Second, cells were seeded
directly into DM and stained 4 d later. In spite of signifi-
cant cell loss that reduced the cell density of M cultures, M
cells formed myotubes; in this case P cells, as expected,
readily differentiated (Fig. 5 
 
A, compare M and P).
The increased cell mortality in response to depletion of
growth factors was suggestive of an apoptotic response, as
seen with Rat-1 fibroblasts overexpressing c-myc (Evan et
al., 1992). To maximize cell death and minimize myotube
formation, cells were grown in GM until one day before
confluence, when the medium was changed to DM. After
24 h of incubation in DM, 40% of subconfluent M cells
compared to 6% of P cells displayed condensed chromatin
and damaged nuclei, hallmarks of apoptotic cell death as
confirmed by electron microscopy (Fig. 6) by the degrada-
tion of DNA into discrete bands visible as a ÒladderÓ on
electrophoretic gels (data not shown) and by the fact that
coexpression of Bcl-2 abrogated the myc-induced increase.
The remaining M cells were sparse but multinucleated, in-
dicative of myogenic fusion (Fig. 5 A).
The transformation potential of M cells was determined
in vitro using a soft agar assay to assess the loss of anchor-
age dependence of growth. M cells formed colonies in soft
agar with an efficiency of 1%, whereas P cells were incapa-
ble of anchorage-independent growth (Table I). No mac-
rocolonies of .500 cells were formed by either P or M
cells. Thus, v-Myc alone does not induce a highly trans-
formed phenotype, consistent with previous results of Fal-
cone et al. (1985) with v-Myc transformed quail myoblasts.
Moreover, v-myc expression had no effect on the latency
of tumor formation in nude mice (see Fig. 9). We hypothe-
sized that the failure of v-Myc to enhance transformation
and tumorigenicity was due to the differentiation and
death responses observed in v-mycÐexpressing myoblast
monolayer cultures in depleted GM or in DM, which
would compound the effect of decreasing local growth fac-
tor concentrations during colony growth. From these data
we conclude that v-Myc stimulates the cell cycle ÒengineÓ
of L6 cells, yet the concomitant increase in the potential to
differentiate or die aborts full transformation.
Figure 1. Immunoblot analysis of parental and total transfectant
cell populations. Total protein lysates were separated by SDS-
PAGE and transferred to a membrane for immunodetection us-
ing (A) pan-myc and (B) Bcl-2 polyclonal antisera. Lane assign-
ments are as follows: P, parental L6, M, v-Myc1 cells, B, Bcl-21
cells. Migration of molecular weight (kD) markers is shown.Screaton et al. CEA, a Dominant Differentiation-blocking Oncogene 943
Bcl-2 Expression Blocks Myc-induced Apoptosis and 
Promotes Cell Overgrowth
In fibroblast cultures overexpressing c-myc, bcl-2 expres-
sion can delay cell death for several days (Bissonette et al.,
1992; Fanidi et al., 1992; Wagner et al., 1993; Zhu et al.,
1996). Therefore, to circumvent cell death and to consoli-
date the stimulation of proliferation induced by v-Myc in
GM we introduced human bcl-2 into parental and v-mycÐ
expressing lines and selected for total populations of cells
stably expressing bcl-2 (B) and both v-myc and bcl-2
(MB). Bcl-2 expression was verified by immunoblot analy-
sis (Fig. 1 B). In the L6 system, Bcl-2 did not alter the divi-
sion rates of P or M cells (Fig. 2, inset, compare P and B, M
and MB). However, a striking increase in cell saturation
density and long term retention of colony forming ability
was observed in all cell populations expressing bcl-2 (Fig.
2, inset, compare M and MB). This was presumably af-
fected by blocking v-MycÐinduced apoptosis and by a re-
duction in acidification of the medium (Table II). These
more benign culture conditions promoted further cell pro-
liferation beyond normal serum growth factor-limited sat-
uration density resulting in a smaller cell size (Fig. 3). The
percentage of subconfluent cells displaying chromatin con-
densation after 24 h in DM is shown in Fig. 6 B. MB cells
demonstrated only 5.5% damaged nuclei (compared with
M at 40%), indicating complete suppression of M cell
death by coexpression of bcl-2. Since P and B cells show
the same low level of apoptosis (Fig. 6 B, and data not
shown), the effect of Bcl-2 in stimulating division at con-
fluence (Fig. 2, compare P and B) is presumably not a con-
sequence of attenuated cell loss. We conclude that Bcl-2
blocks apoptosis and independently allows further cell di-
vision of L6 cells in GM.
Figure 2. Growth parame-
ters of L6 transfectants.
Growth curves are shown
giving the proliferative rate,
saturation density, and via-
bility at saturation of L6 pa-
rental (P), v-Myc (M), Bcl-2
(B), and CEA (C) transfec-
tants and double or triple
transfectants. Cells were
seeded in replicate 60-mm
dishes as described in Mate-
rials and Methods. The data
shown were obtained in one
experiment and are repre-
sentative of three separate
experiments in which the
rates, saturation densities,
and viabilities were all repro-
ducible. The standard error
of the means of three inde-
pendent determinations at
each point was <4% for all
data points, i.e., smaller than
the diameters of the symbols
themselves. (Inset) Doubling
times, initial and 15-d satura-
tion densities, and viabilities
of L6 cell transfectants were
obtained from the data
shown in Fig. 2. Culture via-
bility (see Materials and
Methods) is presented as an
average of the viabilities on
days 10 and 15 and is ex-
pressed as a percentage of
the viability of exponentially
growing cultures. The latter
values varied from 76 to
93%. To normalize for the
effects of differentiation and/
or apoptosis, the number of
cells/plate on days 10 and 15
was taken to be equivalent to
the maximum reached during
the course of the growth
curve.The Journal of Cell Biology, Volume 137, 1997 944
To investigate the effects of Bcl-2 on differentiation, P,
B, and MB cells were tested in the low serum assays. Bcl-2
alone did not disrupt myotube formation in monolayer
culture (Fig. 5), but bcl-2 coexpression with v-myc reduced
the increased fusion index of M in the clonal assay from 75
to 19% (Fig. 4). MB myotubes were smaller and more
densely packed than parental myotubes, making them
more difficult to identify (Fig. 5 A). The majority of MB
cells expressed myosin, however (Fig. 5 B). bcl-2 expres-
sion can therefore abrogate apoptosis induced by v-Myc,
but differentiation is allowed to proceed. In fact, the su-
perposition of Bcl-2 did not increase the efficiency of col-
ony formation of P or M cells in soft agar (Table I), and
MB cells showed a reduction in latency for tumor forma-
tion of only a few weeks (see Fig. 9). We attribute this to
the persistence of differentiation in B and MB cell popula-
tions. In fact, MB tumors contained many myosin-positive
cells, indicating extensive differentiation (Ordonez, C.,
R.A. Screaton, and C.P. Stanners, unpublished observa-
tions).
CEA Blocks Differentiation and Maintains 
Proliferative Potential of L6 and C2 Myoblasts
To affect complete transformation of L6 myoblasts by
Myc and Bcl-2, a gene product that could block myogenic
differentiation was required. We previously reported that
CEA could provide a complete block of both morphologi-
cal and biochemical myogenic differentiation of L6 cells
while leaving the cells with proliferative potential (Eidel-
man et al., 1993). We decided first to characterize the cell
biology of CEA-expressing L6 cells, to check for the gen-
erality of the phenomenon in another myogenic cell line,
and finally to superimpose CEA on MB cells to determine
whether this combination of genes would result in full ma-
lignant transformation. To this end, L6 rat and C2 mouse
myoblasts were transfected with expression vectors con-
taining CEA cDNA (Beauchemin et al., 1987) by calcium
phosphate precipitation. Stable transfectant L6 and C2 to-
tal cell populations were enriched for cell surface CEA by
cytofluorometric sorting after labeling with antiÐhuman
CEA antibody. These total transfectant populations (L6C
or C, C2C) and individual clones (L6C-1) were analyzed
for CEA expression by FACS analysis (Fig. 7, A and C).
The levels of cell surface expression of CEA were within
the range seen by FACS analysis of purified colonocytes
from freshly excised human colon carcinomas (Ilantzis et
al., 1997).
The ability of L6C-1 and C2C myoblasts to differentiate
terminally was evaluated by determining the percentage of
nuclei present in myotubes with increasing time in DM
(Fig. 7, B and D). On day 7 in DM, L6 cells demonstrated
a maximum fusion index of 85%. C2 cells acidified DM
more rapidly than L6 cells and by day 7 in DM were de-
taching from the plate. On day 5 in DM, however, C2 cells
showed a fusion index of 57%. In contrast, cultures of both
L6 and C2 cells stably expressing cell surface CEA showed
dramatically reduced fusion indices; in fact, L6C and L6C-1
cells showed no myotube formation whatsoever (Figs. 5
and 7 B, and data not shown). L6C-1 (Fig. 7 B) and C2C
(Fig. 7 D) myoblasts retained the ability to form colonies
at high efficiency when seeded in GM, even after culture
for several weeks in DM (data not shown). In DM, L6C-1
cells fail to express myogenin mRNA (Eidelman et al.,
1993), and both L6C-1 and C2C cells did not express myo-
sin (Rojas et al., 1996; Fig. 5 B, and data not shown). Thus
myoblasts expressing CEA cannot access even the earliest
stages of the parental differentiation program.
CEA Induces a Reversible G0 Arrest in DM
To determine the characteristics of the cell cycle arrest ef-
fected by CEA, cells from L6C-1 cultures incubated for in-
creasing time in DM were harvested, stained with propid-
ium iodide, and their nuclear DNA content analyzed by
cytofluorometric analysis. Fig. 8 shows that the L6C-1 cells
arrested exclusively with a postmitotic, preDNA synthetic
G1 DNA content. Furthermore, upon addition of FBS
(20%) or PDGF-BB (not shown) to these cells on day 9 in
DM, DNA replication was reinitiated with a lag of 18 h
(Fig. 8). The length of the 18 h lag period was unchanged
after an additional 7 d (not shown), suggesting that L6C-1
cells reach a quiescent state after 9 d that does not deepen
with increasing time in DM. The length of a normal G1
phase was calculated from FACS profiles of DNA content
of exponentially growing L6C-1 cells, by determining the
percentage of cells in either G1, S, or G2/M (Stanners and
Till, 1960), giving a value of 9.6Ð10.0 h. A lag of 18 h there-
fore represents an 8 h prolongation of the normal G1 pe-
riod and suggests that L6C-1 cells enter a G0-like quies-
cent state on or before day 9 in DM. Thus CEA expression
appears to induce cells to enter a viable, reversible G0-like
quiescent state that is incompatible with differentiation
and permanent cell cycle withdrawal. Such a state should
be susceptible to oncogenic activation.
Figure 3. Cell sizes of L6 transfectants corresponding to the
growth curve data of Fig. 2. Cell diameters, as determined by
pulse height analysis of particle count data, are shown.Screaton et al. CEA, a Dominant Differentiation-blocking Oncogene 945
CEA, in Concert with Myc and Bcl-2, Leads to
Full Transformation
Effect on Growth Parameters. We next tested the effect of
CEA expression alone (C) and in combination with v-Myc
and Bcl-2 (MC, BC, and MBC) on the growth behavior,
transformation, and tumorigenicity of the transfectant
cells. The presence of CEA, unlike v-Myc, increased the
doubling time of L6 cells, i.e., slowed the cell cycle, in-
creased the average cell size, and decreased initial satura-
tion density (Figs. 2, inset, and 3). After prolonged culture,
however, CEA caused a surprising slow rise in saturation
density for C, BC, and MBC but not MC cultures (Fig. 2,
inset). This effect was not due to a loss of cell surface CEA
expression as CEA levels remained unchanged during the
course of the growth cycle (data not shown). CEA did not
alter the increase in proliferation rate or the stimulation of
apoptosis induced by v-Myc (compare MC with M in Figs.
2 and 6 B) but did, however, override the stimulatory ef-
fect of v-Myc in stationary phase by reducing the initial
culture saturation density (Fig. 2, compare MC with M).
When CEA expression was superimposed on MB cells
(MBC), the doubling time was shorter and typical of M
cells (Fig. 2, inset), confirming the overriding effect of
v-Myc. The effect of Bcl-2 to annul the v-MycÐinduced in-
crease in apoptosis was also preserved (Fig. 6 B, compare
MB and MBC), as was the ability of both Bcl-2 and CEA
to increase saturation density (Fig. 2, inset). However,
CEA profoundly modified the effects of v-Myc in conflu-
ent serum-limited conditions by blocking the enhanced
differentiation phenotype (Fig. 5). In the growth (Fig. 2),
colony (Fig. 4), and low serum (Fig. 5) assays, the presence
of CEA in every population of transfectants, regardless of
the presence of v-Myc and/or Bcl-2, completely prevented
differentiation as measured by the appearance of multinu-
cleated and/or myosin-positive cells. Thus the Myc, Bcl-2,
and CEA combination seemed to endow L6 cells with the
requisite attributes for full transformation. We tested this
supposition directly using soft agar and tumorigenicity assays.
Effect on Transformation. CEA expression neither con-
ferred anchorage independence upon L6 cells when ex-
pressed alone nor interfered with the low-level soft agar
colony formation induced by v-Myc (Table I). However,
MBC cells produced rare macrocolonies (.500 cells) in
soft agar which did not form in MB plates. These MBC
macrocolonies (MBC-m), when rendered single cells and
reintroduced into soft agar, bred true with an efficiency for
colony formation ranging from 7 to 78% (Table I, and data
not shown). It seemed possible that the macrocolonies
could represent a minority of the MBC population with a
particular set of heritable expression levels for the three
transfected gene products that allowed rapid growth in
soft agar and tumorigenicity in nude mice. Whereas this
hypothesis is impossible to rule out completely, we con-
sider it unlikely since, for CEA at least, nonheritable vari-
ation in expression levels in individual cells exceeds by far
any heritable variability we have been able to reveal by
cloning or FACS sorting. Furthermore, MBC-m and tu-
mor-derived cell lines did not show an increase in the lev-
els of expression of v-Myc and Bcl-2 by immunoblot analy-
Figure 4. Differentiation in the nonprolif-
erating centers of cell colonies. (A) Photo-
micrographs of colonies arising from cells
seeded at clonal density and grown for 10 d
in GM. Representative parental (P) and
v-Myc1 (M) colonies, showing the pres-
ence of myotubes in the centers of only
v-Myc1 colonies. (B) Lower magnifica-
tion of plates from (A). (C) The percent-
age of colonies showing myotubes. Colo-
nies arising after 10-d incubations in GM
were scored for the presence of myotubes.
Average results for two, and for some
lines three, experiments are shown. The
plating efficiencies for colony formation
varied from 50 to 92% between individual
experiments and varied no more than 10%
between cell lines in a given experiment.
Bar: (A) 0.4 mm; (B) 1.7 mm.The Journal of Cell Biology, Volume 137, 1997 946
sis (data not shown). Thus we suggest that MBC-m cells
represent members of the population with additional in-
herited changes endowing them with the ability to grow
more efficiently when deprived of anchorage. Interest-
ingly, very rare macrocolonies were also observed on
plates seeded with cells other than MBC but only with C,
BC, or MC cells, i.e., cells expressing CEA, regardless of
the other genes expressed. These macrocolonies, when
picked and replated, also bred true (Table I), indicating
again the presence of further heritable transforming le-
sions. The expression of CEA thus greatly facilitates the
emergence of cells bearing such lesions.
Effect on Tumorigenicity. Tumorigenicity was assessed
by injection of cells into the thigh muscles of nude mice
(Fig. 9). Interestingly, shorter latent periods were seen for
all cell types expressing CEA (Fig. 9, compare P with C, B
with BC, and MB with MBC), indicating that the presence
of CEA favors a more rapid emergence of malignant cells.
In fact, the presence of CEA alone was capable of reduc-
ing the tumor latent period by 50%. This effect was highly
statistically significant (P , 0.0005 for P vs. C, n 5 6; P ,
0.01 for B vs. BC, n 5 6; P , 0.0005 for MB vs. MBC, n 5
8) and agrees with the observation that soft agar macrocol-
onies were observed only for cell lines expressing CEA, as
noted above. The tumors were examined for their gross
morphology and microscopic histology. Cell lines capable
of differentiation in vitro retained this property in the tu-
mors they formed (Ordonez, C., R.A. Screaton, and C.P.
Stanners, unpublished results). Tumors produced by C
and BC cells appeared within 8 wk but grew slowly and
were contained within the leg muscle (not shown); each
consisted of an amorphous mass of nondifferentiated cells.
MB, MBC, and MBC-m tumors migrated out of the site of
injection to the muscle surface (not shown), indicating a
more aggressive phenotype associated with v-Myc.
The question arose whether the tumors, especially those
with extended latent periods, were composed of cells that
possessed additional genetic lesions selected for during the
growth period in vivo. To test for this, isolated tumors
were rendered suspensions of single cells by collagenase
treatment and evaluated for their resistance to the cyto-
toxic agent(s) used to isolate the original transfectants. A
high percentage of the cells derived from tumors demon-
strated resistance with the expected specificity. The drug
Figure 5. Effects of v-Myc, Bcl-2, and CEA on culture density and differentiation. (A) Photomicrographs of cultures seeded directly in
DM and incubated for 4 d. (B) Photomicrographs of P, C, MB, and MC cultures incubated for 4 d in DM showing immunofluorescence
with anti-myosin antibody and of corresponding fields by phase contrast. Bar: (A) 180 mm; (B) 36 mm.Screaton et al. CEA, a Dominant Differentiation-blocking Oncogene 947
resistant cells were subsequently tested for anchorage in-
dependence of growth. Nearly all, except for those pro-
duced by MBC-m cells, showed an increase in plating effi-
ciency for colonies and macrocolonies in soft agar (Table
I), implicating selection for preexisting or additional ge-
netic changes during tumor growth. Finally, there is the
question whether the MBC-m clones picked from soft agar
themselves exhibited maximum tumorigenicity. Both drug
resistant cells selected from excised MBC-m tumors and
the original MBC-m cells used to produce them were rein-
jected intramuscularly into nude mice. A small but statisti-
cally insignificant decrease in latency was observed for the
tumor-derived cells (not shown). When tested for growth
characteristics in GM, a progressive increase in saturation
density (MBC-m-t . MBC-m . MBC) was noted, indicat-
ing a step-wise evolution of the transformed phenotype
(not shown).
Discussion
The prevailing view of tumorigenesis holds that conver-
sion from a normal to a completely transformed pheno-
type involves a series of oncogenic events (Weinberg,
1989). Since overexpression of CEA represents a major
phenotypic change in a wide variety of human cancers, its
potential contribution to malignant progression represents
a significant question. To directly test the contribution of
CEA expression to tumor progression in vivo, L6 myo-
blasts were used as a model system, as they possess both
proliferation and differentiation potential. The experi-
ments described here provide evidence that CEA can be
considered the prototypic member of a novel class of on-
cogene. Overexpression results in prolonged cell survival,
in a manner distinct from bcl-2, by the dominant inhibition
of terminal differentiation allowing for the outgrowth of
variants bearing genetic alterations, conferring further
growth advantage and subsequent transformation.
The Role of Myc
Deregulated expression of the c-myc gene has been impli-
cated in many types of human cancer (Spencer and Grou-
dine, 1991), and this, in addition to the observed mitogen-
induced changes in c-myc expression (Kelly et al., 1983)
and the requirement for c-myc for the G1ÐS transition,
strongly supports the model that this transcriptional regu-
lator is central to the control of cellular proliferation.
When v-myc, whose phenotypic and molecular effects
have been found to mimic c-myc (Penn et al., 1990), was
expressed in proliferating L6 cells, a reproducible decrease
in the cellular doubling time and a higher maximum cell
density were noted. Although the observed decrease in
doubling time was relatively small, it would quickly result
in the elimination of P cells in an exponentially increasing
mixed population of P and M cells. These effects could be
due to a more efficient use of serum growth factors by
v-mycÐexpressing cells than the parental cells, allowing for
more rapid cell growth, further cell division beyond nor-
mal saturation, and the production of smaller cells (Figs. 2
and 3).
Two additional cellular responses were also greatly
stimulated by v-myc: apoptosis and myogenic differentia-
Figure 6. Frequency of apop-
tosis of L6 transfectants in
DM. (A) Electron micro-
graph showing chromatin
condensation and compac-
tion at the periphery of the
nuclear membrane charac-
teristic of apoptosis in L6
v-Myc1 cells incubated un-
der low serum conditions.
(B) The percentage of nuclei
in L6 transfectant cultures
demonstrating chromatin
condensation when stained
with orcein. Subconfluent
cultures in GM were washed
and incubated in DM for 24 h
before fixation and staining
with orcein. Results are rep-
resentative of several inde-
pendent experiments. Two
cell suspensions and three
fields per cell suspension
were scored, and the results
were averaged. Photomicro-
graphs of subconfluent (C)
parental L6 and (D) v-Myc1
cells stained with orcein show-
ing condensation of chroma-
tin and damaged nuclei (ar-
rows) in v-Myc1 cells. Bar:
(A) 4 mm; (C and D) 40 mm.The Journal of Cell Biology, Volume 137, 1997 948
tion. These anti-transforming effects were apparent when
growth factors became limiting and were presumably re-
sponsible for the failure of M cells to form colonies effi-
ciently in soft agar or to reduce the latency of tumor for-
mation. The commonly observed effect of c-myc triggering
apoptosis (Bissonnette et al., 1992; Evan et al., 1992;
Fanidi et al., 1992; Hermeking and Eick, 1994; Wagner et
al., 1994) is thus duplicated with v-myc in this system. Inhi-
bition of myogenic differentiation at the morphological
(Falcone et al., 1985; Crescenzi et al., 1994; La Rocca et al.,
1994) or biochemical (Falcone et al., 1985; Denis et al.,
1987; La Rocca et al., 1994) level by Myc, however, has
been reported by most observers under differentiation
conditions. Thus, our observation of a dramatic stimula-
tion of differentiation appears to be unique. We feel that
these differences with our findings could be due to system-
dependent differences in the balance between Myc-induced
apoptosis and differentiation, which both require reduced
growth factor concentrations for execution. Our results
are not due to a coincidence of myotube formation in a
subpopulation of M cells that escaped apoptosis, since the
M population formed colonies with high efficiency in GM,
and 75% of these showed differentiation. This represented
a very significant stimulation of differentiation relative to
the parental cells, which showed 0% differentiated colo-
nies under the same conditions (Fig. 4).
The Role of Bcl-2
The superposition of bcl-2 expression on L6 cells produc-
ing v-Myc had no effect on the acceleration of cell division
Table II. Medium pH of L6 Transfectants
Cell line pH DpH
Medium 7.54 Ñ
P 7.71 10.17
M 6.89 20.65
MB 7.50 20.04
Bcl-2 prevents v-Myc acidification of culture medium. pH values were determined
for pooled medium (GM) from 10 individual plates after 9 d of the growth curve
shown in Fig. 2.
Table I. Anchorage Independent Growth of L6 Transfectants 
and Derived Macrocolony (m) and Tumor (t) Lines
Plating efficiency
(%)
Cell line .100 cells .500 cells
P 0.0 0.0
M 1.0 0.0
B 0.1 0.0
C 0.2 0.05 (1)
MB 0.3 0.0
BC 0.3 0.10 (4)
MC 1.1 0.03 (1)
MBC 0.2 0.03 (11)
C-m 7.5 3.3
BC-m 4.0 0.5
MBC-m1 27 8.9
MBC-m2 52 23
MBC-m3 0.03 0.0
MBC-m4 6.6 1.7
MBC-mpool#1 35 12
MBC-mpool#2 18 12
P-t 13 5.6
C-t 6.5 1.9
B-t 0.3 0.0
BC-t 18 8.7
MB-t 0.4 0.07
MBC-t 10 1.2
MBC-m2-t 51 22
MBC-mpool#1-t 39 9.3
Efficiencies for anchorage independent colony growth of L6 transfectants and deriva-
tive macrocolony (-m) and tumor (-t) cell lines. 103 cells were seeded in each of three
replicate dishes in 0.3% agar in GM, and colonies of .100 and .500 cells (macrocol-
onies) were counted after incubation for 4 wk. Results for the first eight lines shown
(from P to MBC) represent the average of two to six independent determinations; the
bracketed figures represent the total number of macrocolonies seen in all experiments.
MBC-mpool#1 was composed of an equal ratio of MBC-m1 through MBC-m4.
MBC-mpool#2 was composed of three independent macrocolony cell lines, MBC-
m5, -m6, and -m7 (not shown). MBC-m3 failed to form colonies with increased effi-
ciency. Tumor (-t) cell lines were obtained by explantation of tumor cell suspensions
and selection for cells capable of growth in vitro in the presence of appropriate selec-
tive drugs.
Figure 7. CEA transfectants of L6 and C2 myoblasts retain divi-
sion potential in DM. FACS profiles (A) of parental rat L6 cells
(P), CEA transfectant clone (C-1) and CEA total transfectant
population (C), and (C) mouse C2 and CEA transfectant total
population (C2C) labeled with rabbit antiÐhuman CEA antibod-
ies. In all cases, anti-CEA immunoreactivity was detected using
goat antiÐrabbit FITC-conjugated antibody, as described in Ma-
terials and Methods. (B) L6 and (D) C2 cells expressing CEA re-
tain division potential in DM, as measured by their ability to form
colonies in GM. Cells were seeded in GM on day 23, and the me-
dium was changed to DM on day 0. To calculate percentage via-
bility, colony numbers were normalized to values obtained on
day 2 in GM (day 21 in DM). Fusion indices are shown by dotted
lines.Screaton et al. CEA, a Dominant Differentiation-blocking Oncogene 949
induced by v-Myc (Fig. 2, inset) but completely suppressed
apoptosis (Fig. 6 C). This is consistent with results from
other systems, as overexpression of c-myc in cultured fi-
broblasts can induce both accelerated proliferation and
apoptosis (Evan et al., 1992), with the latter being delayed
by coexpression of bcl-2 (Bissonnette et al., 1992; Fanidi et
al., 1992; Wagner et al., 1993). Our results further indicate
a transforming activity of Bcl-2 in addition to its ability to
inhibit apoptosis. L6 cells expressing bcl-2 alone reach
higher saturation densities than the parental line (Fig. 2,
inset), independent of any effect on cell death (Fig. 6 B). In
the colony assay, MB colonies on average were twice the
size of M colonies (not shown). In addition, cultures of L6
cells expressing bcl-2, regardless of the other oncogenes
present, remained viable for prolonged culture periods
without medium change (Fig. 2). This evidence, together
with the growth characteristics of these lines (Fig. 2), sug-
gests that Bcl-2 lowers the serum requirement for further
cell division at normal saturation and, in v-Myc1 cells,
blocks apoptosis allowing for their overgrowth in increas-
ingly limiting serum. Positive effects of bcl-2 expression on
cell growth parameters have been previously reported for
3T3 fibroblasts (Reed et al., 1991) and pro-B cells (Miya-
zaki et al., 1995). Interestingly, the Bcl-2Ðmediated block
of apoptosis coincided with a failure to rapidly acidify the
culture medium (Table II). The role of medium acidifica-
tion in v-MycÐinduced apoptosis in L6 cells is currently
under investigation.
B cell directed expression of c-myc and bcl-2 together in
transgenic mice resulted in the formation of monoclonal
tumors (Strasser et al., 1990). By contrast, L6 cells express-
ing both v-myc and bcl-2 were not fully transformed, as
they were unable to form normal-sized colonies in soft
agar and did not give rise to any larger macrocolonies (Ta-
ble I). We attribute this failure to the persistence of differ-
entiation, thus abrogating the emergence of variants with
more transformed properties. When tested in vivo, a sig-
nificant but relatively small reduction in tumor latent pe-
riod by MB cells was noted relative to M or B cells, though
MB tumors were found to contain many differentiated
cells (Fig. 9, and Ordonez, C., R.A. Screaton, and C.P.
Stanners, unpublished observations).
The Role of CEA
We have shown previously that ectopic cell surface CEA
expression by L6 myoblasts blocks entry to the myogenic
differentiation program at a very early stage, i.e., before
the upregulation of the myogenic transcriptional regula-
tor, myogenin (Eidelman et al., 1993). Cells expressing
CEA alone were slowed in their division rate and reached
lower initial saturation densities (Fig. 2). In cells produc-
ing both CEA and v-Myc, v-Myc was dominant in acceler-
ating cell proliferation but succumbed to the effects of
CEA at confluence. We suggest that these effects of CEA
are due to an increase in the probability in DM of cells en-
tering a G0-like state from the G1 period of the cell cycle
(Figs. 7 and 8). Since the parental cells tend to differenti-
ate under these conditions, it is difficult to determine
whether this state is entirely novel or a state transiently
traversed by the parental cells during their passage to dif-
ferentiation. CEA was confirmed to block differentiation
in this study and was dominant over the differentiation
stimulating effect of v-Myc in MC cells, blocking differen-
tiation completely.
Cells expressing v-myc, bcl-2, and CEA together pos-
sessed all of the properties expected to yield a fully trans-
formed phenotype: a higher division rate, a higher satura-
tion density, reduced apoptosis, no differentiation, and
long term survival (Figs. 2 and 4Ð6) yet did not produce
colonies in soft agar with high efficiency (Table I). MBC
cell populations did, however, contain cells at low fre-
Figure 8. L6C-1 cells enter a
viable quiescent state in DM.
Flow cytofluorometric pro-
files of DNA content of L6
and L6C-1 nuclei stained
with propidium iodide. (A)
After 9 d in DM, cells were
stimulated by the addition of
20% FBS and harvested (B)
18 h and (C) 24 h later. Cells
were lysed with 0.1% Triton
X-100 in 0.1% sodium citrate
supplemented with 10 mg/ml
RNase and stained with 50
mg/ml propidium iodide.
DNA content of the nuclear
suspensions was determined
by FACS analysis.
Figure 9. Tumorigenicity of L6 transfectants. The average latent
period in weeks of the different transfectant cell lines for tumor
formation is displayed as solid bars. Results represent the aver-
age of two separate experiments. MBC-m is a cell population
generated by pooling four different MBC macrocolonies isolated
from soft agar and is termed MBC-mpool#1 in Table I.The Journal of Cell Biology, Volume 137, 1997 950
quency capable of producing very large anchorage inde-
pendent macrocolonies which, when picked and dispersed,
bred true, forming macrocolonies with high efficiency (Ta-
ble I). Interestingly, macrocolonies were found in all cell
cultures in which CEA was expressed: MBC, MC, BC, and
even C cell populations (Table I). These variants also
seemed to be responsible for the formation of tumors,
since the latent periods for tumor formation were lowest
for cell lines containing them (Fig. 9), the cells selected for
during tumor growth were highly enriched for them (Ta-
ble I), and pure populations of variant cells showed the
lowest tumor latency.
ÒFertile SoilÓ Hypothesis
From these results, we suggest that CEA expression accel-
erates progression towards transformation and increased
tumorigenicity by blocking terminal differentiation, thus
providing a Òfertile soilÓ for the emergence of cellular
variants with increased proliferative potential. Indeed, af-
ter reaching an initial stationary phase, all cell lines ex-
pressing CEA tend to increase slowly in cell number (Fig.
2), indicating an increased sensitivity to proliferative stim-
uli. CEA-expressing cell lines also accumulate tumorigenic
macrocolony-producing cells, as noted above. The nature
of the heritable changes giving rise to macrocolonies is
presently unknown. Bcl-2 has also been suggested to pro-
vide a cellular state conducive to the emergence of more
autonomous variants, yet accomplishes this by a funda-
mentally different mechanism, i.e., by the suppression of
apoptosis. In transgenic mice, ectopic bcl-2 expression
alone does not directly result in tumors (McDonnell et al.,
1989) yet generates a population of quiescent cells that
possesses oncogenic potential, perhaps as a consequence
of extended survival (McDonnell and Korsmeyer, 1991).
In the L6 system, however, Bcl-2 was relatively ineffective
in promoting the emergence of variants or decreasing tu-
mor latency. Thus CEA seems to posess a novel oncogenic
activity, with a distinct mechanism from Bcl-2 for the in-
duction of a long term viable quiescence (Fig. 10).
Relevance In Vivo
CEA is expressed at low levels in the proliferative zone of
the colonic crypt epithelium in normal adult colonocytes
(Ahnen et al., 1987; Jothy et al., 1993). As colonocytes dif-
ferentiate, losing division potential, they migrate up the
sides of the crypt towards the lumen of the gut. During this
process, CEA is upregulated on the luminal (apical) sur-
face of these cells (Ahnen et al., 1987; Jothy et al., 1993).
Our present model outlining a possible role for CEA in co-
lon tumorigenesis contends that overproduction of CEA
over the entire surface of colonocytes that still possess di-
vision potential, i.e., out of the context of a normal cellular
differentiation program, could result in such cells retaining
inappropriate proliferative capacity. The intercellular ad-
hesion activity of CEA could lead to the disruption of nor-
mal cellÐcell and cellÐsubstratum interactions that are pre-
sumably required both for the maintenance of tissue
architecture and for faithful completion of colonocyte dif-
ferentiation (Benchimol et al., 1989). By disrupting cellÐ
cell interactions expected to be important for normal dif-
ferentiation, CEA-positive cells would experience extended
survival and remain open to further growth stimuli or on-
cogenic activation.
Perhaps the most relevant system for examining the ef-
fect of CEA is therefore the human colonic epithelium
where CEA family members, CEA, nonspecific cross-react-
ing antigen, and biliary glycoprotein, undergo dramatic
changes in expression during carcinogenesis (Cournoyer
et al., 1988; Boucher et al., 1989; Hinoda et al., 1991; Neu-
maier et al., 1993). The technical complexity and poorly
defined differentiation process of the colonic system, how-
ever, renders it less amenable to experimental investiga-
tion in vitro. The results presented in this work refer to a
myoblast model system chosen for ease of experimenta-
tion and interpretation and with assumed relevance to sys-
tems where CEA is naturally expressed. The results, which
support the above hypothesis, are not species or cell line
specific in that the basic observation of the induction of a
viable quiescent cellular state in which myogenic differen-
tiation is blocked was extended to mouse C2 myoblasts
(Fig. 7). We are currently investigating the effect of CEA
expression on other differentiating systems.
The validity of the use of the myoblast system is sup-
ported by our recent observations that CEA and nonspe-
cific cross-reacting antigen, both of which block myogenic
differentiation (Eidelman et al., 1993; Rojas et al., 1996),
are upregulated on the surface of purified colon carcinoma
cells relative to normal colonocytes from the same patient
and at levels inversely related to the degree of differentia-
tion, while biliary glycoprotein, which has no effect on
myogenic differentiation (Rojas et al., 1996), shows no in-
crease in expression (Ilantzis et al., 1997). An upregulation
of CEA was also observed in early dysplastic lesions of the
colon (Ilantzis et al., 1997). Interestingly, both bcl-2 upreg-
ulation (Bedi et al., 1995; Bosari et al., 1995; Sinicrope et
al., 1995) and myc overexpression (Guillem et al., 1995,
and references therein) have been reported to be involved in
a high proportion of human colon adenomas and carcinomas.
The effect of CEA on myogenesis is similar to that of
oncogenic forms of H-ras and N-ras (Olson et al., 1987), as
the block in differentiation is not dependent on aberrant
proliferation. A major difference in the effects of CEA
and ras, however, is the reduction in saturation density
mediated by CEA (Fig. 2, inset), which precludes placing
CEA and ras in the same category of oncogene. As the
CEA effect is reversible by supplementing DM with pep-
tides corresponding to the CEA adhesion domains (Eidel-
man et al., 1993), it is tempting to speculate that the CEAÐ
CEA interaction may interfere directly with intracellular
signaling events required for activation of the myogenic
differentiation program. In fact, we have shown that CEA
can signal through its GPI anchor to phosphorylate Src
family kinases and other cellular proteins (Draber, P., un-
published observations) and that the GPI anchor is abso-
lutely required for the inhibitory effect on myogenic differ-
entiation (Screaton, R.A., and C.P. Stanners, unpublished
observations).
CEA: A Dominant Differentiation-blocking Oncogene?
Can CEA be considered an oncogene? Often protoonco-
genes are found to comprise ubiquitous elements of the
cell proliferation or differentiation machinery (Hunter,Screaton et al. CEA, a Dominant Differentiation-blocking Oncogene 951
1991; 1993). CEA does not have a known counterpart
within the genomes of oncogenic viruses and does not pos-
sess overt transforming properties in cultured cells. Does
CEA function as an inducer of quiescence in normal
growth control of all cells? The restricted expression pat-
tern of CEA makes this unlikely. However, CEA could be
used as an explicit (as opposed to ligand controlled) differ-
entiation block during embryonic development, in situa-
tions where cells are required to remain associated in un-
differentiated collectives. We suggest that inappropriate
expression of CEA in adult life in cells with both prolifera-
tion and differentiation capacity promotes survival in the
presence of differentiation stimuli, thus facilitating the ac-
quisition of progressive mutations. We therefore propose
that CEA defines a new class of gene with dominant, dif-
ferentiation-blocking oncogenic activity.
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